Skip to main content
Erschienen in: Current Treatment Options in Oncology 12/2021

01.12.2021 | Head and Neck Cancer (JL Geiger, Section Editor)

Overview and Emerging Trends in the Treatment of Osteoradionecrosis

verfasst von: Joseph B. Meleca MD, Emily Zhang MD, Michael A. Fritz MD, Peter J Ciolek MD

Erschienen in: Current Treatment Options in Oncology | Ausgabe 12/2021

Einloggen, um Zugang zu erhalten

Opinion statement

Osteoradionecrosis (ORN) of the mandible is a rare but devastating complication which occurs following radiation therapy for head and neck malignancies. Left untreated, ORN often results in pathologic fracture of the mandible leading to pain, trismus, difficulty eating, and overall poor quality of life. Historically, early intervention relied on hyperbaric oxygen and local debridement. Patients whose disease progressed despite therapy required segmental resection of the mandible with osseous free flap reconstruction, a highly invasive operation. Patients that presented with a moderate disease without pathologic fracture were often doomed to fail non-operative management, ultimately leading to disease progression and fracture. The traditional dichotomous treatment paradigm left a void of options for patients with moderate disease. The ideal intervention for this category of patients would provide renewed vascularity to the diseased tissue bed allowing for the osteogenesis and reestablishment of strong, load-bearing bone. The innovative technique termed the vascularized fascia lata “rescue flap” has proven to be an effective treatment for moderate ORN and will likely transform dated treatment algorithms.
Literatur
1.
Zurück zum Zitat Teng M, Futran ND. Osteoradionecrosis of the mandible. Curr Opin Otolaryngol Head Neck Surg. 2005;13:217–21.CrossRef Teng M, Futran ND. Osteoradionecrosis of the mandible. Curr Opin Otolaryngol Head Neck Surg. 2005;13:217–21.CrossRef
2.••
Zurück zum Zitat Marx R. A new concept in the treatment of osteoradionecrosis. J Oral Maxillofac Surg. 1983;41:351–7. Establishes the most widely used classification and staging system for ORN today.CrossRef Marx R. A new concept in the treatment of osteoradionecrosis. J Oral Maxillofac Surg. 1983;41:351–7. Establishes the most widely used classification and staging system for ORN today.CrossRef
3.
Zurück zum Zitat Park L, Lilic N, Addison B, et al. Cost analysis of osteoradionecrosis. J Laryngol Otol. 2017;131(4):303–8.CrossRef Park L, Lilic N, Addison B, et al. Cost analysis of osteoradionecrosis. J Laryngol Otol. 2017;131(4):303–8.CrossRef
4.•
Zurück zum Zitat Raggio BS, Winters R. Modern management of osteoradionecrosis. Curr Opin Otolaryngol Head Neck Surg. 2018;26(4):254–9.A recent and comprehensive review covering current management options for ORN.CrossRef Raggio BS, Winters R. Modern management of osteoradionecrosis. Curr Opin Otolaryngol Head Neck Surg. 2018;26(4):254–9.A recent and comprehensive review covering current management options for ORN.CrossRef
5.
Zurück zum Zitat Buglione M, Cavagnini R, Di Rosario F, et al. Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement. Crit Rev Oncol Hematol. 2016;97:131–42.CrossRef Buglione M, Cavagnini R, Di Rosario F, et al. Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement. Crit Rev Oncol Hematol. 2016;97:131–42.CrossRef
6.
Zurück zum Zitat Aarup-Kristensen S, Hansen CR, Forner L, et al. Osteoradionecrosis of the mandible after radiotherapy for head and neck cancer: risk factors and dose-volume correlations. Acta Oncol. 2019;58(10):1373–7.CrossRef Aarup-Kristensen S, Hansen CR, Forner L, et al. Osteoradionecrosis of the mandible after radiotherapy for head and neck cancer: risk factors and dose-volume correlations. Acta Oncol. 2019;58(10):1373–7.CrossRef
7.
Zurück zum Zitat MD Anderson Head Neck Cancer Symptom Working Group. Dose-volume correlates of mandibular osteoradionecrosis in oropharynx cancer patients receiving intensity-modulated radiotherapy: results from a case-matched comparison. Radiother Oncol. 2017;124:232–9.CrossRef MD Anderson Head Neck Cancer Symptom Working Group. Dose-volume correlates of mandibular osteoradionecrosis in oropharynx cancer patients receiving intensity-modulated radiotherapy: results from a case-matched comparison. Radiother Oncol. 2017;124:232–9.CrossRef
8.
Zurück zum Zitat De Felice F, Musio D, Tombolini V. Osteoradionecrosis and intensity modulated radiation therapy: an overview. Crit Rev Oncol Hematol. 2016;107:39–43.CrossRef De Felice F, Musio D, Tombolini V. Osteoradionecrosis and intensity modulated radiation therapy: an overview. Crit Rev Oncol Hematol. 2016;107:39–43.CrossRef
9.
Zurück zum Zitat Dhanda J, Pasquier D, Newman L, Shaw R. Current concepts in osteoradionecrosis after head and neck radiotherapy. Clin Oncol (R Coll Radiol). 2016;28:459–66.CrossRef Dhanda J, Pasquier D, Newman L, Shaw R. Current concepts in osteoradionecrosis after head and neck radiotherapy. Clin Oncol (R Coll Radiol). 2016;28:459–66.CrossRef
10.
Zurück zum Zitat Wang TH, Liu CJ, Chao TF, et al. Risk factors for and the role of dental extractions in osteoradionecrosis of the jaws: a national-based cohort study. Head Neck. 2017;39:1313–21.CrossRef Wang TH, Liu CJ, Chao TF, et al. Risk factors for and the role of dental extractions in osteoradionecrosis of the jaws: a national-based cohort study. Head Neck. 2017;39:1313–21.CrossRef
11.•
Zurück zum Zitat Rivero JA, Shamji O, Kolokythas A. Osteoradionecrosis: a review of pathophysiology, prevention and pharmacologic management using pentoxifylline, a-tocopherol, and clodronate. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017;124:464–71. A review covering the evidence on using PENTOCLO in conservative management of ORN.CrossRef Rivero JA, Shamji O, Kolokythas A. Osteoradionecrosis: a review of pathophysiology, prevention and pharmacologic management using pentoxifylline, a-tocopherol, and clodronate. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017;124:464–71. A review covering the evidence on using PENTOCLO in conservative management of ORN.CrossRef
12.
Zurück zum Zitat Sathasivam HP, Davies GR, Boyd NM. Predictive factors for osteoradionecrosis of the jaws: a retrospective study. Head Neck. 2018;40:46–54.CrossRef Sathasivam HP, Davies GR, Boyd NM. Predictive factors for osteoradionecrosis of the jaws: a retrospective study. Head Neck. 2018;40:46–54.CrossRef
13.
Zurück zum Zitat Marx R. J Oral Maxillofac Surg. Osteoradionecrosis: a new concept of its pathophysiology. 1983;41:203-280. Marx R. J Oral Maxillofac Surg. Osteoradionecrosis: a new concept of its pathophysiology. 1983;41:203-280.
14.
Zurück zum Zitat Dambrain R. The pathogenesis of osteoradionecrosis. Rev Stomatol Chir Maxillofac. 1993;94:140–7.PubMed Dambrain R. The pathogenesis of osteoradionecrosis. Rev Stomatol Chir Maxillofac. 1993;94:140–7.PubMed
15.
Zurück zum Zitat Assael LA. New foundations in understanding osteonecrosis of the jaws. J Oral Maxillofac Surg. 2004;62:125–6.CrossRef Assael LA. New foundations in understanding osteonecrosis of the jaws. J Oral Maxillofac Surg. 2004;62:125–6.CrossRef
16.
Zurück zum Zitat Al-Nawas B, Duschner H, Grotz KA. Early cellular alterations in bone after radiation therapy and its relation to osteoradionecrosis (letter). J Oral Maxilofac Surg. 2004;62:1045.CrossRef Al-Nawas B, Duschner H, Grotz KA. Early cellular alterations in bone after radiation therapy and its relation to osteoradionecrosis (letter). J Oral Maxilofac Surg. 2004;62:1045.CrossRef
17.
Zurück zum Zitat Delanian S, Lefaix JL. The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway. Radiother Oncol. 2004;73:119–31.CrossRef Delanian S, Lefaix JL. The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway. Radiother Oncol. 2004;73:119–31.CrossRef
18.
Zurück zum Zitat Pasquier D, Hoelscher T, Schmutz J, et al. Hyperbaric oxygen therapy in the treatment of radio-induced lesions in normal tissues: a literature review. Radiother Oncol. 2004;72:1–13.CrossRef Pasquier D, Hoelscher T, Schmutz J, et al. Hyperbaric oxygen therapy in the treatment of radio-induced lesions in normal tissues: a literature review. Radiother Oncol. 2004;72:1–13.CrossRef
19.
Zurück zum Zitat Annane D, Depondt J, Aubert P, et al. Hyperbaric oxygen therapy for radionecrosis of the jaw: a randomized, placebo-controlled, double-blind trial from the ORN96 study group. J Clin Oncol. 2004;22:4893–900.CrossRef Annane D, Depondt J, Aubert P, et al. Hyperbaric oxygen therapy for radionecrosis of the jaw: a randomized, placebo-controlled, double-blind trial from the ORN96 study group. J Clin Oncol. 2004;22:4893–900.CrossRef
20.
Zurück zum Zitat Haffey TM, Winters R, Kerr R, Fritz MA. Mandibular rescue: application of the ALT fascia free flap to arrest osteoradionecrosis of the mandible. Am J Otolaryngol. 2019;40(6):102262.CrossRef Haffey TM, Winters R, Kerr R, Fritz MA. Mandibular rescue: application of the ALT fascia free flap to arrest osteoradionecrosis of the mandible. Am J Otolaryngol. 2019;40(6):102262.CrossRef
21.
Zurück zum Zitat Devine CM, Haffey TM, Trosman S, et al. Short-stay hospital admission after free tissue transfer for head and neck reconstruction. Laryngoscope. 2016;126(12):2679–83.CrossRef Devine CM, Haffey TM, Trosman S, et al. Short-stay hospital admission after free tissue transfer for head and neck reconstruction. Laryngoscope. 2016;126(12):2679–83.CrossRef
22.
Zurück zum Zitat Liu ZJ, Xiong XP, Zhao YF. Osteoradionecrosis of the zygoma. J Craniofac Surg. 2017;28(6):e577–9.CrossRef Liu ZJ, Xiong XP, Zhao YF. Osteoradionecrosis of the zygoma. J Craniofac Surg. 2017;28(6):e577–9.CrossRef
23.
Zurück zum Zitat Pitak-Arnnop P, Sader R, Dhanuthai K, et al. Management of osteoradionecrosis of the jaws: an analysis of evidence. Eur J Surg Oncol. 2008;34(10):1123–34.CrossRef Pitak-Arnnop P, Sader R, Dhanuthai K, et al. Management of osteoradionecrosis of the jaws: an analysis of evidence. Eur J Surg Oncol. 2008;34(10):1123–34.CrossRef
24.
Zurück zum Zitat Delanian S, Chatel C, Porcher R, Depondt J, Lefaix JL. Complete restoration of refractory mandibular osteoradionecrosis by prolonged treatment with a pentoxifylline-tocopherol-clodronate combination (PENTOCLO): a phase II trial. Int J Radiat Oncol Biol Phys. 2011;80(3):832–9.CrossRef Delanian S, Chatel C, Porcher R, Depondt J, Lefaix JL. Complete restoration of refractory mandibular osteoradionecrosis by prolonged treatment with a pentoxifylline-tocopherol-clodronate combination (PENTOCLO): a phase II trial. Int J Radiat Oncol Biol Phys. 2011;80(3):832–9.CrossRef
25.
Zurück zum Zitat Zhou Z, Lang M, Fan W, et al. Prevention of osteoradionecrosis of the jaws by low-intensity ultrasound in the dog model. Int J Oral Maxillofac Surg. 2016;45(9):1170–6.CrossRef Zhou Z, Lang M, Fan W, et al. Prevention of osteoradionecrosis of the jaws by low-intensity ultrasound in the dog model. Int J Oral Maxillofac Surg. 2016;45(9):1170–6.CrossRef
26.
Zurück zum Zitat Harris M. The conservative management of osteoradionecrosis of the mandible with ultrasound therapy. Br J Oral Maxillofac Surg. 1992;30(5):313–8.CrossRef Harris M. The conservative management of osteoradionecrosis of the mandible with ultrasound therapy. Br J Oral Maxillofac Surg. 1992;30(5):313–8.CrossRef
27.•
Zurück zum Zitat Bennett MH, Feldmeier J, Hampson NB, Smee R, Milross C. Hyperbaric oxygen therapy for late radiation tissue injury. Cochrane Database Syst Rev. 2016;4:CD005005. The most recent Cochrane review regarding the use of HBO for osteoradionecrosis.PubMed Bennett MH, Feldmeier J, Hampson NB, Smee R, Milross C. Hyperbaric oxygen therapy for late radiation tissue injury. Cochrane Database Syst Rev. 2016;4:CD005005. The most recent Cochrane review regarding the use of HBO for osteoradionecrosis.PubMed
28.
Zurück zum Zitat Moen I, Stuhr LE. Hyperbaric oxygen therapy and cancer–a review. Target Oncol. 2012;7(4):233–42.CrossRef Moen I, Stuhr LE. Hyperbaric oxygen therapy and cancer–a review. Target Oncol. 2012;7(4):233–42.CrossRef
29.
Zurück zum Zitat Marx RE, Johnson RP, Kline SN. Prevention of osteoradionecrosis: a randomized prospective clinical trial of hyperbaric oxygen versus penicillin. J Am Dent Assoc. 1985;111:49–54.CrossRef Marx RE, Johnson RP, Kline SN. Prevention of osteoradionecrosis: a randomized prospective clinical trial of hyperbaric oxygen versus penicillin. J Am Dent Assoc. 1985;111:49–54.CrossRef
30.•
Zurück zum Zitat Shaw RJ, Butterworth CJ, Silcocks P, et al. HOPON (Hyperbaric Oxygen for the Prevention of Osteoradionecrosis): a randomized controlled trial of hyperbaric oxygen to prevent osteoradionecrosis of the irradiated mandible after dentoalveolar surgery. Int J Radiat Oncol Biol Phys. 2019;104(3):530–9. The most recent randomized controlled trial demonstrating lack of efficacy of HBO in preventing ORN.CrossRef Shaw RJ, Butterworth CJ, Silcocks P, et al. HOPON (Hyperbaric Oxygen for the Prevention of Osteoradionecrosis): a randomized controlled trial of hyperbaric oxygen to prevent osteoradionecrosis of the irradiated mandible after dentoalveolar surgery. Int J Radiat Oncol Biol Phys. 2019;104(3):530–9. The most recent randomized controlled trial demonstrating lack of efficacy of HBO in preventing ORN.CrossRef
31.
Zurück zum Zitat Dai T, Tian Z, Wang Z, Qiu W, Zhang Z, He Y. Surgical management of osteoradionecrosis of the jaws. J Craniofac Surg. 2015;26(2):e175–9.CrossRef Dai T, Tian Z, Wang Z, Qiu W, Zhang Z, He Y. Surgical management of osteoradionecrosis of the jaws. J Craniofac Surg. 2015;26(2):e175–9.CrossRef
32.
Zurück zum Zitat Lee M, Chin RY, Eslick GD, Sritharan N, Paramaesvaran S. Outcomes of microvascular free flap reconstruction for mandibular osteoradionecrosis: a systematic review. J Craniomaxillofac Surg. 2015;43(10):2026–33.CrossRef Lee M, Chin RY, Eslick GD, Sritharan N, Paramaesvaran S. Outcomes of microvascular free flap reconstruction for mandibular osteoradionecrosis: a systematic review. J Craniomaxillofac Surg. 2015;43(10):2026–33.CrossRef
33.
Zurück zum Zitat Pautke C, Tischer T, Neff A, Horch HH, Kolk A. In vivo tetracycline labeling of bone: an intraoperative aid in the surgical therapy of osteoradionecrosis of the mandible. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102(6):e10–3.CrossRef Pautke C, Tischer T, Neff A, Horch HH, Kolk A. In vivo tetracycline labeling of bone: an intraoperative aid in the surgical therapy of osteoradionecrosis of the mandible. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102(6):e10–3.CrossRef
34.
Zurück zum Zitat Kraeima J, Steenbakkers RJHM, Spijkervet FKL, Roodenburg JLN, Witjes MJH. Secondary surgical management of osteoradionecrosis using three-dimensional isodose curve visualization: a report of three cases. Int J Oral Maxillofac Surg. 2018;47(2):214–9.CrossRef Kraeima J, Steenbakkers RJHM, Spijkervet FKL, Roodenburg JLN, Witjes MJH. Secondary surgical management of osteoradionecrosis using three-dimensional isodose curve visualization: a report of three cases. Int J Oral Maxillofac Surg. 2018;47(2):214–9.CrossRef
35.
Zurück zum Zitat Ghai S, Sharma Y, Jain N, Satpathy M, Pillai AK. Use of 3-D printing technologies in craniomaxillofacial surgery: a review. Oral Maxillofac Surg. 2018;22(3):249–59.CrossRef Ghai S, Sharma Y, Jain N, Satpathy M, Pillai AK. Use of 3-D printing technologies in craniomaxillofacial surgery: a review. Oral Maxillofac Surg. 2018;22(3):249–59.CrossRef
36.
Zurück zum Zitat Kashiwa K, Kobayashi S, Nohara T, et al. Efficacy of distraction osteogenesis for mandibular reconstruction in previously irradiated areas: clinical experiences. J Craniofac Surg. 2008;19(6):1571–6.CrossRef Kashiwa K, Kobayashi S, Nohara T, et al. Efficacy of distraction osteogenesis for mandibular reconstruction in previously irradiated areas: clinical experiences. J Craniofac Surg. 2008;19(6):1571–6.CrossRef
Metadaten
Titel
Overview and Emerging Trends in the Treatment of Osteoradionecrosis
verfasst von
Joseph B. Meleca MD
Emily Zhang MD
Michael A. Fritz MD
Peter J Ciolek MD
Publikationsdatum
01.12.2021
Verlag
Springer US
Erschienen in
Current Treatment Options in Oncology / Ausgabe 12/2021
Print ISSN: 1527-2729
Elektronische ISSN: 1534-6277
DOI
https://doi.org/10.1007/s11864-021-00915-3

Weitere Artikel der Ausgabe 12/2021

Current Treatment Options in Oncology 12/2021 Zur Ausgabe

Cardio-oncology (MG Fradley, Section Editor)

The Importance of Primary Care in Cardio-Oncology

Palliative and Supportive Care (MP Davis, Section Editor)

Treating Chronic Pain with Buprenorphine—The Practical Guide

Neuro-oncology (GJ Lesser, Section Editor)

Systemic Therapy for Lung Cancer Brain Metastases

Gynecologic Cancers (LA Cantrell, Section Editor)

COVID-19 and Gynecologic Oncology: What Have We Learned?

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.